M. Pieroni

Exhaled nitric oxide in interstitial lung diseases

D. Bennett, E. Bargagli, R. M. Refini, 2014, Respiratory Physiology & Neurobiology.

NK and NKT-like cells in granulomatous and fibrotic lung diseases

E. Bargagli, R. M. Refini, P. Sestini, 2019, Clinical and Experimental Medicine.

Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study

E. Bargagli, P. Sestini, C. Landi, 2020, Internal medicine journal.

Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies

E. Bargagli, R. M. Refini, P. Cameli, 2019, Inflammation.

Exhaled carbon monoxide in sarcoidosis.

E. Bargagli, P. Rottoli, P. Sestini, 2008, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.

Robert J. Desnick, Christine M. Eng, Matteo A. Russo, 2001, The New England journal of medicine.

Immunosuppressive treatment of chronic non-viral myocarditis.

M. Pieroni, A. Frustaci, C. Chimenti, 2006, Ernst Schering Research Foundation workshop.

Giant cell myocarditis responding to immunosuppressive therapy.

M. Pieroni, A. Frustaci, C. Chimenti, 2000, Chest.